CONMED (CNMD) Revenue & Revenue Breakdown
CONMED Revenue Highlights
Latest Revenue (Y)
$1.24B
Latest Revenue (Q)
$316.70M
Main Segment (Y)
General Surgery
Main Geography (Y)
UNITED STATES
CONMED Revenue by Period
CONMED Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $1.24B | 19.06% |
| 2022-12-31 | $1.05B | 3.45% |
| 2021-12-31 | $1.01B | 17.18% |
| 2020-12-31 | $862.46M | -9.70% |
| 2019-12-31 | $955.10M | 11.11% |
| 2018-12-31 | $859.63M | 7.94% |
| 2017-12-31 | $796.39M | 4.31% |
| 2016-12-31 | $763.52M | 6.17% |
| 2015-12-31 | $719.17M | -2.08% |
| 2014-12-31 | $734.47M | -2.95% |
| 2013-12-31 | $756.75M | -1.35% |
| 2012-12-31 | $767.14M | 5.80% |
| 2011-12-31 | $725.08M | 1.59% |
| 2010-12-31 | $713.72M | 2.73% |
| 2009-12-31 | $694.74M | -6.39% |
| 2008-12-31 | $742.18M | 6.90% |
| 2007-12-31 | $694.29M | 7.34% |
| 2006-12-31 | $646.81M | 4.78% |
| 2005-12-31 | $617.30M | 10.55% |
| 2004-12-31 | $558.39M | 12.32% |
| 2003-12-31 | $497.13M | 9.73% |
| 2002-12-31 | $453.06M | 5.68% |
| 2001-12-31 | $428.72M | 9.30% |
| 2000-12-31 | $392.23M | 5.27% |
| 1999-12-31 | $372.60M | 10.76% |
| 1998-12-31 | $336.40M | 143.24% |
| 1997-12-31 | $138.30M | 10.11% |
| 1996-12-31 | $125.60M | 26.10% |
| 1995-12-31 | $99.60M | 40.08% |
| 1994-12-30 | $71.10M | 32.65% |
| 1993-12-31 | $53.60M | - |
CONMED generated $1.24B in revenue during NA 2023, up 19.06% compared to the previous quarter, and up 144.80% compared to the same period a year ago.
CONMED Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-09-30 | $316.70M | -4.25% |
| 2024-06-30 | $330.75M | 6.13% |
| 2024-03-31 | $311.63M | -4.71% |
| 2023-12-31 | $327.05M | 7.38% |
| 2023-09-30 | $304.58M | -4.12% |
| 2023-06-30 | $317.65M | 7.51% |
| 2023-03-31 | $295.47M | 17.78% |
| 2022-12-31 | $250.87M | -8.80% |
| 2022-09-30 | $275.09M | -0.76% |
| 2022-06-30 | $277.19M | 14.39% |
| 2022-03-31 | $242.33M | -11.55% |
| 2021-12-31 | $273.97M | 10.11% |
| 2021-09-30 | $248.83M | -2.48% |
| 2021-06-30 | $255.16M | 9.66% |
| 2021-03-31 | $232.68M | -7.97% |
| 2020-12-31 | $252.83M | 6.30% |
| 2020-09-30 | $237.84M | 50.73% |
| 2020-06-30 | $157.78M | -26.27% |
| 2020-03-31 | $214.01M | -19.20% |
| 2019-12-31 | $264.87M | 13.39% |
| 2019-09-30 | $233.59M | -1.96% |
| 2019-06-30 | $238.26M | 9.11% |
| 2019-03-31 | $218.38M | -9.93% |
| 2018-12-31 | $242.44M | 19.84% |
| 2018-09-30 | $202.31M | -4.94% |
| 2018-06-30 | $212.82M | 5.32% |
| 2018-03-31 | $202.06M | -9.21% |
| 2017-12-31 | $222.56M | 17.06% |
| 2017-09-30 | $190.12M | -3.57% |
| 2017-06-30 | $197.15M | 5.67% |
| 2017-03-31 | $186.57M | -8.59% |
| 2016-12-31 | $204.09M | 10.45% |
| 2016-09-30 | $184.79M | -4.47% |
| 2016-06-30 | $193.43M | 6.75% |
| 2016-03-31 | $181.20M | -5.14% |
| 2015-12-31 | $191.02M | 12.90% |
| 2015-09-30 | $169.18M | -6.54% |
| 2015-06-30 | $181.03M | 1.73% |
| 2015-03-31 | $177.94M | -8.03% |
| 2014-12-31 | $193.47M | 11.43% |
| 2014-09-30 | $173.63M | -7.04% |
| 2014-06-30 | $186.78M | 3.43% |
| 2014-03-31 | $180.59M | -10.56% |
| 2013-12-31 | $201.91M | 13.54% |
| 2013-09-30 | $177.83M | -7.18% |
| 2013-06-30 | $191.59M | 3.32% |
| 2013-03-31 | $185.43M | -7.86% |
| 2012-12-31 | $201.24M | 10.64% |
| 2012-09-30 | $181.88M | -4.12% |
| 2012-06-30 | $189.69M | -2.38% |
| 2012-03-31 | $194.32M | 4.71% |
| 2011-12-31 | $185.58M | 7.39% |
| 2011-09-30 | $172.81M | -5.69% |
| 2011-06-30 | $183.24M | -0.12% |
| 2011-03-31 | $183.45M | -0.34% |
| 2010-12-31 | $184.08M | 6.90% |
| 2010-09-30 | $172.19M | -4.91% |
| 2010-06-30 | $181.09M | 2.68% |
| 2010-03-31 | $176.37M | -7.48% |
| 2009-12-31 | $190.63M | 8.64% |
| 2009-09-30 | $175.47M | 6.63% |
| 2009-06-30 | $164.57M | 0.31% |
| 2009-03-31 | $164.06M | -8.47% |
| 2008-12-31 | $179.25M | -0.09% |
| 2008-09-30 | $179.41M | -6.92% |
| 2008-06-30 | $192.75M | 1.04% |
| 2008-03-31 | $190.77M | 0.64% |
| 2007-12-31 | $189.57M | - |
CONMED generated $316.70M in revenue during Q3 2024, up -4.25% compared to the previous quarter, and up 99.70% compared to the same period a year ago.
CONMED Revenue Breakdown
CONMED Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 23 | Dec 22 |
|---|---|---|
| Orthopedic Surgery | $533.16M | $461.53M |
| General Surgery | $711.59M | $583.94M |
CONMED's latest annual revenue breakdown by segment (product or service), as of Dec 23: General Surgery (57.17%), and Orthopedic Surgery (42.83%).
Quarterly Revenue by Product
| Product/Service | Sep 24 | Jun 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Sep 22 | Jun 22 | Mar 22 | Sep 21 | Jun 21 | Mar 21 | Sep 20 | Jun 20 | Mar 20 | Sep 19 | Jun 19 | Mar 19 | Sep 18 | Jun 18 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| General Surgery | $186.16M | $192.56M | $190.52M | $179.91M | $176.86M | $164.29M | $156.47M | $157.01M | $134.81M | $143.08M | $147.27M | $125.51M | $135.65M | $97.30M | $114.73M | $123.26M | $122.51M | $104.94M | $99.38M | $102.69M |
| Orthopedic Surgery | $130.54M | $139.54M | $136.53M | $124.67M | $140.79M | $131.18M | $118.62M | $120.18M | $107.52M | $105.75M | $107.89M | $107.17M | $102.19M | $60.48M | $99.28M | $110.33M | $115.76M | $113.44M | $102.93M | $110.13M |
CONMED's latest quarterly revenue breakdown by segment (product or service), as of Sep 24: General Surgery (58.78%), and Orthopedic Surgery (41.22%).
CONMED Revenue Breakdown by Country
Annual Revenue by Country
| Country | Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 |
|---|---|---|---|---|---|
| UNITED STATES | $700.16M | $1.16B | $158.55M | $139.72M | $179.42M |
| Americas (excluding the United States) | $120.93M | $212.21M | $63.82M | $50.36M | $64.27M |
| Asia Pacific | $197.40M | $324.95M | $107.59M | $93.64M | $101.33M |
| EMEA | $226.25M | $395.87M | $108.46M | $91.00M | $118.30M |
CONMED's latest annual revenue breakdown by geography, as of Dec 23: UNITED STATES (56.25%), EMEA (18.18%), Asia Pacific (15.86%), and Americas (excluding the United States) (9.72%).
Quarterly Revenue by Country
| Country | Sep 24 | Jun 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Americas (excluding the United States) | $28.82M | $31.64M | $49.99M | $29.33M | $22.62M | $18.99M | $17.42M | $17.77M | $19.99M | $16.17M | $16.61M | $16.12M | $13.71M | $17.38M | $15.20M | $13.77M | $5.58M | $15.80M | $16.38M | $17.07M |
| EMEA | $55.52M | $63.69M | $109.11M | $51.44M | $32.58M | $33.12M | $24.69M | $26.91M | $32.06M | $29.98M | $31.13M | $24.16M | $27.12M | $26.05M | $28.27M | $23.10M | $13.71M | $25.91M | $32.10M | $24.69M |
| UNITED STATES | $183.15M | $185.37M | $428.35M | $170.52M | $52.34M | $48.94M | $49.08M | $45.69M | $40.46M | $37.95M | $42.69M | $37.96M | $40.78M | $37.13M | $42.38M | $38.91M | $21.39M | $37.04M | $48.30M | $42.53M |
| Asia Pacific | $49.21M | $51.41M | $80.75M | $53.28M | $33.25M | $30.12M | $24.02M | $28.24M | $27.67M | $23.42M | $27.19M | $27.52M | $26.28M | $26.60M | $26.90M | $26.40M | $19.80M | $20.54M | $27.02M | $26.04M |
CONMED's latest quarterly revenue breakdown by geography, as of Sep 24: UNITED STATES (57.83%), EMEA (17.53%), Asia Pacific (15.54%), and Americas (excluding the United States) (9.10%).
CONMED Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| STE | STERIS | $5.14B | $1.28B |
| ITGR | Integer | $1.60B | $746.27M |
| GMED | Globus Medical | $1.57B | $629.69M |
| CNMD | CONMED | $1.24B | $316.70M |
| LIVN | LivaNova | $1.15B | $318.11M |
| IRTC | iRhythm | $492.68M | $147.54M |
| ATEC | Alphatec | $482.26M | $47.99M |
| GKOS | Glaukos | $314.71M | $95.69M |
| ANIK | Anika Therapeutics | $166.66M | $41.92M |
| KIDS | OrthoPediatrics | $148.73M | $52.80M |
| SIBN | SI-BONE | $138.89M | $39.97M |
| SRDX | Surmodics | $132.58M | $30.34M |
| SGHT | Sight Sciences | $81.06M | $21.37M |
| LUNG | Pulmonx | $68.67M | $20.39M |
| OFIX | Orthofix Medical | $100.00K | $198.62M |
CNMD Revenue FAQ
What is CONMED’s yearly revenue?
CONMED's yearly revenue for 2023 was $1.24B, representing an increase of 19.06% compared to 2022. The company's yearly revenue for 2022 was $1.05B, representing an increase of 3.45% compared to 2021. CNMD's yearly revenue for 2021 was $1.01B, representing an increase of 17.18% compared to 2020.
What is CONMED’s quarterly revenue?
CONMED's quarterly revenue for Q3 2024 was $316.7M, a -4.25% decrease from the previous quarter (Q2 2024), and a 3.98% increase year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $330.75M, a 6.13% increase from the previous quarter (Q1 2024), and a 4.12% increase year-over-year (Q2 2023). CNMD's quarterly revenue for Q1 2024 was $311.63M, a -4.71% decrease from the previous quarter (Q4 2023), and a 5.47% increase year-over-year (Q1 2023).
What is CONMED’s revenue growth rate?
CONMED's revenue growth rate for the last 3 years (2021-2023) was 23.16%, and for the last 5 years (2019-2023) was 30.33%.
What are CONMED’s revenue streams?
CONMED's revenue streams in c 23 are Orthopedic Surgery, and General Surgery. Orthopedic Surgery generated $533.16M in revenue, accounting 42.83% of the company's total revenue, up 15.52% year-over-year. General Surgery generated $711.59M in revenue, accounting 57.17% of the company's total revenue, up 21.86% year-over-year.
What is CONMED’s main source of revenue?
For the fiscal year ending Dec 23, the largest source of revenue of CONMED was General Surgery. This segment made a revenue of $711.59M, representing 57.17% of the company's total revenue.